| Structure | Chemical Name | CAS | MF |
|
DAPM
|
208255-51-0
|
C20H20F2N2O4
|
|
DAPK SUBSTRATE PEPTIDE
|
386769-53-5
|
C70H115N25O17
|
|
DAPP1 (Dual Adaptor of Phosphotyrosine and 3-Phosphoinositides, Bam32)
|
|
|
|
Dapoxetine-d6 Hydrochloride
|
1246814-76-5
|
C21H24ClNO
|
|
Dapoxetine N-Oxide
|
|
C21H23NO2
|
|
|
Dapoxyl 3
|
|
|
|
|
DAPOXYL(R) 3-SULFONAMIDOPHENYLBORONIC ACID
|
|
|
|
Dapoxetine hydrochloride
|
129938-20-1
|
C21H24ClNO
|
|
DAPOXYL(R) 3-SULFONAMIDOPROPIONIC ACID, SUCCINIMIDYL ESTER
|
|
C13H12N4O11S
|
|
|
DAPOXYL(R) CARBOXYLIC ACID, SUCCINIMIDYL ESTER
|
|
|
|
DAPOXYL(R) (2-BROMOACETAMIDOETHYL)SULFONAMIDE
|
|
C10H11BrN4O8S
|
|
DAPOXYL(R) 2-(3-(2-PYRIDYLDITHIO)PROPIONAMIDOETHYL)SULFONAMIDE
|
|
C16H17N5O8S3
|
|
|
DAPOXYL(R) SULFONYL CHLORIDE
|
|
|
|
|
Dapoxetine-d7
|
|
C21H16NOD7
|
|
|
DAPOXYL(R) SULFONYL HYDRAZINE
|
|
|
|
|
DAPOXYL(R) (2-AMINOETHYL)SULFONAMIDE
|
|
|
|
Dapoxetine
|
119356-77-3
|
C21H23NO
|
|
|
DAPOXYL(R) SULFONIC ACID, SODIUM SALT
|
|
|
|
|
Dapoxetine,LifestyleDrugs
|
|
|
|
dapoxyl sulfonamide
|
|
C6H5N3O7S
|
|
|
Dapoxyl 2
|
|
|
|
|
Dapoxyl
|
|
|
|
|
DAP5 Polyclonal Antibody
|
|
|
|
|
DAP3 Polyclonal Antibody
|
|
|
|
|
DAP1 Polyclonal Antibody
|
|
|
|
|
DAP12 Polyclonal Antibody
|
|
|
|
|
DAPP1 protein
|
|
|
|
|
DAP-1 protein
|
|
|
|
|
Dbf4 protein
|
|
|
|
|
DAP protocol
|
|
|
|
|
DAP-5 protein
|
|
|
|
|
DAP10 protein
|
|
|
|
|
DAP12 protein
|
|
|
|
|
Dap160 protein
|
|
|
|
|
DAP-2 protein
|
|
|
|
|
DBF4 protein, Chinese hamster
|
|
|
|
DAR-2
|
261351-45-5
|
C28H32N4O3
|
|
DBH
|
125118-55-0
|
C11H11N5O2
|
|
DAR-1
|
261351-43-3
|
C28H33N4O3.Cl
|
|
D:B-Friedo-B':A'-neogammacer-5-en-3β-ol
|
1615-94-7
|
C30H50O
|
|
D:B-Friedo-B':A'-neogammacer-5-ene
|
1615-95-8
|
C30H50
|
|
D:B-Friedo-B':A'-neogammacer-5-ene-2β,3β-diol
|
2734-35-2
|
C30H50O2
|
|
|
D:B-Friedo-B':A'-neogammacer-1(10)-ene
|
|
|
|
(+)-D:B-Friedoolean-5-ene-3β,29-diol
|
99891-87-9
|
C30H50O2
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-ILE-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-THR-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-PHE-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-PRO-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-LEU-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-LYS-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-MET-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-SER-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-TRP-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-TYR-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-GLN-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-GLY-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-HIS-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
D-A2PR(NMA)-GLY-[PHE/ALA/VAL/GLU/ARG]-[PRO/TYR/LYS/ILE/ASP]-GLU-ALA-PHE-PRO-LYS(DNP)-D-ARG-D-ARG TRIFLUOROACETATE
|
|
|
|
|
DA41 protein
|
|
|
|
|
DA11 protein
|
|
|
|
|
D6.1A protein
|
|
|
|
|
(DAP22)-SHK
|
220384-25-8
|
C166H274N54O48S7
|
|
DAP10 SIGNALING FRAGMENT
|
|
C74H118N22O24S
|
|
DAPT
|
|
C23H26F2N2O4
|
|
DAPT
|
208255-80-5
|
C23H26F2N2O4
|
|
|
Daptazole Hydrochloride
|
|
|
|
Dapsone HydroxylaMine-d4
|
1330185-26-6
|
C12H12N2O3S
|
|
DAPSONE-D4
|
1346602-12-7
|
C12H12N2O2S
|
|
|
Dapson VETRANAL
|
|
|
|
Dapsone N-β-D-Glucuronide SodiuM Salt
|
54749-81-4
|
C18H19N2NaO8S
|
|
|
DAP213 solution
|
|
|
|
DAPSONE-UL-PHENYL-14C
|
|
C12H12N2O2S
|
|
DAPSONE-D8
|
|
C12H4D8N2O2S
|
|
|
DAPSONE USP(CRM STANDARD)
|
|
|
|
|
DAPSONE BP STANDARD(CRM STANDARD)
|
|
|
|
|
DAPSONE ASSAY STANDARD BP(CRM STANDARD)
|
|
|
|
Dapsone-D8 (major)
|
557794-38-4
|
C12H4D8N2O2S
|
|
Dapsone Hydroxylamine Deuterated
|
198486-78-1
|
C15H17D3O4
|
|
Dapsone Hydroxylamine-D8 (Major)
|
1189668-47-0
|
C12H12N2O3S
|
|
|
DAPSONE WHO(CRM STANDARD)
|
|
|
|
|
Dapsone(Avlosulfon)
|
|
|
|
DAPSONE HYDROXYLAMINE
|
32695-27-5
|
C12H12N2O3S
|
|
|
DAPSONE EPD(CRM STANDARD)
|
|
|
|
1-D-Arabinofuranosyl-1H-pyriMidine-2,4-dione 13C,15N2 2',3',5'-Tribenzoate
|
|
C30H24N2O9
|
|
D-arabino-1,3,4-Trihydroxy-2-aMinoeicosane
|
|
C20H43NO3
|
|
D-Arabinofuranose, tetraacetate
|
61826-42-4
|
C13H18O9
|
|
D-Arabinofuranoside, Methyl, triacetate
|
90244-44-3
|
C12H18O8
|
|
D-ARABONIC ACID POTASSIUM SALT
|
|
C5H9KO6
|
|
D-arabino-Hex-1-enitol, 1,5-anhydro-2-deoxy-6-S-phenyl-6-thio-, diacetate
|
88111-84-6
|
C16H18O5S
|
|
D-arabino-Hex-1-enitol, 1,5-anhydro-2-deoxy-3,4,6-tris-O-(phenylmethyl)-1-C-(phenylsulfonyl)-
|
64978-35-4
|
C33H32O6S
|
|
D-arabino-Hex-5-enitol, 2,6-anhydro-5-deoxy-6-C-(1,3-diphenyl-2-imidazolidinyl)-, 1,3,4-triacetate
|
228115-83-1
|
C27H30N2O7
|
|
D-ArabonicAcid-y-Lactone
|
|
C5H8O5
|
|
D-Arabinose-2-D
|
288846-87-7
|
C5H10O5
|
|
D-Arabinonic acid, 2-C-methyl-4,5-O-(1-methylethylidene)-,ethyl ester
|
93635-76-8
|
C11H20O6
|
|
2-(D-ARABINO-TETRAHYDROXYBUTYL)-4(R)-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID
|
110270-13-8
|
C8H15NO6S
|
|
D-arabino-Hexonic acid, 2,6-dideoxy-3-C-methyl-, delta-lactone (9CI)
|
501951-34-4
|
C7H12O4
|
|
D-arabino-Hept-2-enitol, 2,6-anhydro-1,3-dideoxy-1,1,1-trifluoro- (9CI)
|
333353-54-1
|
C7H9F3O4
|
|
D-arabino-Hexopyranos-3-ulose, 1,6-anhydro-, beta- (8CI)
|
17371-38-9
|
C6H8O5
|
|
D-arabino-Pentodialdo-5,2-furanoside, methyl 3,4-O-(1-methylethylidene)- (9CI)
|
821792-69-2
|
C9H14O5
|